EC Number | Application | Comment | Organism |
---|---|---|---|
6.3.2.4 | drug development | the enzyme is a target for drug development. Acinetobacter baumannii is emerging as a multidrug-resistant nosocomial pathogen, that causes a number of diseases, including pneumonia, bacteremia, meningitis, and skin infections | Acinetobacter baumannii |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
6.3.2.4 | purified recombinant enzyme, development of several different crystallization conditions for the AbDDL protein, e.g. sitting drop vapor diffusion method, 14°C, by mixing of 0.06 M MgCl2 and CaCl2, 0.1 M imidazole, 2-(N-morpholino)ethanesulfonic acid-HCl, pH 6.5, with 30% of the precipitant EDO-P8K containing 40% v/v ethylene glycol and 20% w/v PEG 8000, or by microbatch method with 0.2 M NaSCN and 20% w/v PEG 3350 as crystallization solution, X-ray diffraciton structure determination and analysis at 2.2 A resolution, molecular replacement wit the DDL crystal structure from Yestis pestis as a template, PDB ID 3v4z | Acinetobacter baumannii |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
6.3.2.4 | 3-chloro-2,2-dimethyl-N-[4-(trifluoromethyl)phenyl]propanamide | binding structure, overview | Acinetobacter baumannii | |
6.3.2.4 | D-cycloserine | - |
Acinetobacter baumannii | |
6.3.2.4 | additional information | proposed inhibitor binding site structure, overview | Acinetobacter baumannii | |
6.3.2.4 | phosphorylated D-ala-D-alpha-hydroxybutyrate phosphonate | binding structure, overview | Acinetobacter baumannii |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
6.3.2.4 | additional information | - |
additional information | steady-state kinetics of the Michaelis-Menten equation with a single binding site | Acinetobacter baumannii | |
6.3.2.4 | 0.008 | - |
D-alanine | pH 7.8, 45°C, first D-Ala | Acinetobacter baumannii | |
6.3.2.4 | 1.7 | - |
ATP | pH 7.8, 45°C, first D-Ala | Acinetobacter baumannii | |
6.3.2.4 | 2.7 | - |
D-alanine | pH 7.8, 45°C, second D-Ala | Acinetobacter baumannii |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
6.3.2.4 | Mg2+ | required | Acinetobacter baumannii |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
6.3.2.4 | ATP + 2 D-alanine | Acinetobacter baumannii | - |
ADP + phosphate + D-alanyl-D-alanine | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
6.3.2.4 | Acinetobacter baumannii | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
6.3.2.4 | ATP + 2 D-alanine | - |
Acinetobacter baumannii | ADP + phosphate + D-alanyl-D-alanine | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
6.3.2.4 | More | the asymmetric unit contains six protomers of AbDDL. Five protomers have a closed conformation in the central domain, while one protomer has an open conformation in the central domain. The central domain with an open conformation does not interact with crystallographic symmetry-related protomers and the conformational change of the central domain is not due to crystal packing. The central domain of AbDDL can have an ensemble of the open and closed conformations before the binding of substrate ATP. Active site structure determination and comparison, closed and open conformations of the central domain, overview | Acinetobacter baumannii |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
6.3.2.4 | AbDDL | - |
Acinetobacter baumannii |
6.3.2.4 | Ddl | - |
Acinetobacter baumannii |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
6.3.2.4 | 45 | - |
assay at | Acinetobacter baumannii |
EC Number | Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
6.3.2.4 | 30.08 | - |
D-alanine | pH 7.8, 45°C | Acinetobacter baumannii |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
6.3.2.4 | 7.8 | - |
assay at | Acinetobacter baumannii |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
6.3.2.4 | ATP | the interdomain crevice between the central domain and the C-terminal domain contains the conserved nucleotide binding site, nucleotide binding site structure, overveiw | Acinetobacter baumannii |
EC Number | General Information | Comment | Organism |
---|---|---|---|
6.3.2.4 | additional information | the crystal structure of the D-alanine-D-alanine ligase from Acinetobacter baumannii suggests a flexible conformational change in the central domain before nucleotide binding. The central domain of AbDDL can have an ensemble of the open and closed conformations before the binding of substrate ATP. The conformational change of the central domain is important for the catalytic activity. The conformational change does not result from crystal packing. The central domain is connected to the N-terminal and C-terminal domains through two parallel loops | Acinetobacter baumannii |
6.3.2.4 | physiological function | the D-alanine-D-alanine ligase (DDL) catalyzes the ATP-dependent synthesis of D-alanyl-D-alanine. D-Ala-D-ala is a key component of the bacterial cell wall and it maintains cell wall stability through cross-linking the peptide chain of peptidoglycan | Acinetobacter baumannii |
EC Number | kcat/KM Value [1/mMs-1] | kcat/KM Value Maximum [1/mMs-1] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
6.3.2.4 | 11.14 | - |
D-alanine | pH 7.8, 45°C, second D-Ala | Acinetobacter baumannii | |
6.3.2.4 | 3760.4 | - |
D-alanine | pH 7.8, 45°C, first D-Ala | Acinetobacter baumannii |